NCT02294357 2023-11-01Weekly 70 mg/m2 Carfilzomib for Multiple Myeloma Patients Refractory to 27 mg/m2 CarfilzomibOncotherapeuticsPhase 2 Terminated45 enrolled
NCT02206425 2023-10-31Ixazomib as a Replacement for Carfilzomib and Bortezomib for Multiple Myeloma PatientsOncotherapeuticsPhase 1/2 Completed45 enrolled
NCT00004232 2012-06-01Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerNorthwestern UniversityPhase 1 Completed
NCT00357084 2010-09-14Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell TransplantFred Hutchinson Cancer CenterPhase 2 Completed53 enrolled